1. (a) Reportable conditions.

   1. (1) The cases of cancer to be reported to the division are as follows:

      1. (A) all neoplasms with a behavior code of two or three in the most current edition of the International Classification on Diseases for Oncology (ICD-O) of the World Health Organization with the exception of those designated by the division as non-reportable in the cancer reporting handbook; and
      2. (B) all benign and borderline neoplasms of the central nervous system.
   2. (2) Codes and taxa of the most current edition of the International Classification of Diseases, Clinical Modification of the World Health Organization which correspond to the division's reportable list are specified in the cancer reporting handbook.

2. (b) Reportable information.

   1. (1) The data required to be reported for each cancer case shall include:

      1. (A) name, address, zip code, and county of residence;
      2. (B) social security number, date of birth, gender, race and ethnicity, marital status, and birthplace, to the extent such information is available from the medical record;
      3. (C) information on industrial or occupational history, to the extent such information is available from the medical record;
      4. (D) diagnostic information including the cancer site and laterality, cell type, tumor behavior, grade and size, stage of disease, date of diagnosis, diagnostic confirmation method, sequence number, and other primary tumors;
      5. (E) first course of cancer-related treatment, including dates and types of procedures;
      6. (F) text information to support cancer diagnosis, stage treatment codes, unless another method acceptable to the division is used to confirm these codes;
      7. (G) health care facility or practitioner related information including reporting institution number, type of reporting source, medical record number, registry number, tumor record number, class of case, date of first contact, date of last contact, vital status, institution referred from, institution referred to, date abstracted, abstractor, and electronic record version; and
      8. (H) clinical laboratory related information including laboratory name and address, pathology case number, pathology report date, and referring physician name and address.

   2. (2) Each report shall:

      1. (A) be legible and contain all data items required in paragraph (1) of this subsection;
      2. (B) be in a format prescribed by the division;
      3. (C) meet all quality assurance standards utilized by the division;
      4. (D) in the case of individuals who have more than one form of cancer, be submitted separately for each primary cancer diagnosed;
      5. (E) be submitted to the division electronically, or manually if electronic means are unavailable; and the annual cancer caseload of the health care facility, clinical laboratory or health care practitioner is 50 or fewer cases; and
      6. (F) be transported by secure means at all times to protect the confidentiality of the data.

Source Note:The provisions of this §91.4 adopted to be effective August 6, 1998, 23 TexReg 7801; amended to be effective November 7, 2002, 27 TexReg 10387; amended to be effective April 24, 2003, 28 TexReg 3332.